Psoralen UVA therapy for linear and generalized morphea.
Morison
W L
WL
Department of Dermatology, Johns Hopkins University, Baltimore, Maryland, USA.
D000293:Adolescent; D000328:Adult; D017484:Dermatitis, Phototoxic / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008730:Methoxsalen / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011701:PUVA Therapy; D017319:Photosensitizing Agents / Q000009:adverse effects / Q000627:therapeutic use; D012074:Remission Induction; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects
D017319:Photosensitizing Agents; D008730:Methoxsalen